Acro Biomedical (ACBM) Other Accumulated Expenses (2022 - 2026)

Acro Biomedical has reported Other Accumulated Expenses for 5 years, with the latest figure at $1100.0 in Q2 2026.

• On a quarterly basis, Other Accumulated Expenses changed N/A year-over-year to $1100.0 in Q2 2026; TTM through Jun 2026 was $1100.0, a N/A change from a year earlier, with the FY2025 full-year figure at $1100.0, changed 0.0% from the prior year.
• Other Accumulated Expenses was $1100.0 for Q2 2026 at Acro Biomedical, roughly flat from $1100.0 in the prior quarter.
• The five-year high for Other Accumulated Expenses was $88796.0 in Q4 2023, with the low at $1100.0 in Q4 2024.
• Average Other Accumulated Expenses over 5 years is $46995.7, with a median of $78826.0 recorded in 2022.
• The sharpest annual moves came in 2023 and 2024: Other Accumulated Expenses rose 12.65% in 2023, then plunged 98.76% in 2024.
• Over 5 years, Other Accumulated Expenses stood at $78826.0 in 2022, then increased by 12.65% to $88796.0 in 2023, then slumped by 98.76% to $1100.0 in 2024, then changed by 0.0% to $1100.0 in 2025, then changed by 0.0% to $1100.0 in 2026.
• The last three Other Accumulated Expenses figures came in at $1100.0 (Q2 2026), $1100.0 (Q4 2025), and $1100.0 (Q4 2024), per Business Quant data.